Investment
Features
FeesSafety
Academy
More
Pluang+

Compare GTS Internasional Tbk. (GTSI) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

GTS Internasional Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

GTS Internasional Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? GTS Internasional Tbk. trades at Rp182 (market cap 2.85T, 18.22M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp236 (market cap 164.65B, 62.5K 24h volume). The key difference: GTS Internasional Tbk. is far larger — about 17.3× Brigit Biofarmaka Teknologi Tbk.'s market cap, and GTS Internasional Tbk. is more actively traded (18.22M versus 62.5K). Which is the better fit depends on your goals.

GTSIOBAT
Market Cap
2.85T164.65B
Volume
18.22M62.5K
Lot
182.17K625
Turnover
3.28B15.03M
Average Price
180.26240.55
Value
3.28B15.03M
Indicative Equilibrium Price
182238
Indicative Equilibrium Volume
4.43K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

GTSI
View details
OBAT
View details

About GTS Internasional Tbk.

PT GTS Internasional Tbk (the “Company”) was established based on Notarial Deed No. 32 dated June 29, 2012 of Martina, S.H. The Company started its commercial operations in August 2019. The Company’s parent entity is PT Hateka Trans Internasional and ultimate parent entity is PT Humpuss Intermoda Transportasi Tbk.

Read more on GTSI

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT